5 Oct 2026, 16:28
Director Interests—
CHMCHIMERIC THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
5 Oct 2026, 16:27
Director Interests—
5 Oct 2026, 16:26
Director Interests—
1 Oct 2026, 10:16
Periodic Reports—
1 Oct 2026, 09:34
OtherMS
29 Sept 2026, 16:50
Securities Administration—
22 Sept 2026, 12:32
Securities Administration—
4 Sept 2026, 12:22
Securities Administration—
31 Aug 2026, 17:36
Financial ResultsMS
27 Aug 2026, 17:03
Securities Administration—
21 Aug 2026, 12:45
Securities Administration—
19 Aug 2026, 09:08
Company UpdateMS
17 Aug 2026, 09:53
Trading Halt / SuspensionMS
7 Aug 2026, 12:04
Securities Administration—
31 July 2026, 15:03
Quarterly ReportsMS
29 July 2026, 14:10
Capital RaisingMS
28 July 2026, 11:19
Presentations—
22 July 2026, 16:50
Securities Administration—
17 July 2026, 17:26
Securities Administration—
17 July 2026, 17:25
Securities Administration—
16 July 2026, 09:04
Company UpdateMS
14 July 2026, 17:11
Securities Administration—
14 July 2026, 16:28
Securities Administration—
7 July 2026, 14:41
Director Interests—
6 July 2026, 09:01
Company Administration—
2 July 2026, 16:24
Securities Administration—
1 July 2026, 09:01
Company UpdateMS
11 June 2026, 17:08
Securities Administration—
1 June 2026, 16:52
Securities Administration—
1 June 2026, 08:27
Company UpdateMS
20 May 2026, 17:09
Securities Administration—
12 May 2026, 17:32
Securities Administration—
12 May 2026, 17:25
Securities Administration—
12 May 2026, 17:20
Securities Administration—
8 May 2026, 17:33
Securities Administration—
5 May 2026, 17:02
Securities Administration—
5 May 2026, 14:07
Substantial Holders—
4 May 2026, 16:45
Securities Administration—
4 May 2026, 16:25
Securities Administration—
4 May 2026, 16:20
Securities Administration—
1 May 2026, 17:30
Securities Administration—
30 Apr 2026, 11:40
Securities Administration—
30 Apr 2026, 11:25
Securities Administration—
29 Apr 2026, 15:41
Quarterly ReportsMS
29 Apr 2026, 09:30
Securities Administration—
29 Apr 2026, 09:23
Securities Administration—
27 Apr 2026, 09:15
Company UpdateMS
17 Apr 2026, 12:34
Securities Administration—
17 Apr 2026, 12:22
Meetings & Governance—
9 Apr 2026, 16:28
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 16:28 | Final Director's Interest Notice - LR | Director Interests | — | 02010 | |
| 5 Oct 2026, 16:27 | Final Director's Interest Notice - BG | Director Interests | — | 02010 | |
| 5 Oct 2026, 16:26 | Initial Director's Interest Notice - RM | Director Interests | — | 02008 | |
| 1 Oct 2026, 10:16 | FY2026 Annual Report, creditor update and Board changes | Periodic Reports | — | 03014, 12001, 12008, 12017, 12019 | |
| 1 Oct 2026, 09:34 | Suspension from Quotation | Other | MS | — | |
| 29 Sept 2026, 16:50 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 22 Sept 2026, 12:32 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 4 Sept 2026, 12:22 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 31 Aug 2026, 17:36 | Appendix 4E and Preliminary Final Report | Financial Results | MS | 03003 | |
| 27 Aug 2026, 17:03 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 21 Aug 2026, 12:45 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 19 Aug 2026, 09:08 | CHM ceases enrolment in Phase 1 trial and Company update | Company Update | MS | 03027, 09014, 11001 | |
| 17 Aug 2026, 09:53 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 7 Aug 2026, 12:04 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 31 July 2026, 15:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 29 July 2026, 14:10 | Chimeric receives $1.62M advance on FY26 R&D tax incentive | Capital Raising | MS | 03022, 11001 | |
| 28 July 2026, 11:19 | Investor Presentation | Presentations | — | 03026 | |
| 22 July 2026, 16:50 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 17 July 2026, 17:26 | Notification regarding unquoted securities - CHM | Securities Administration | — | 06021 | |
| 17 July 2026, 17:25 | Notification regarding unquoted securities - CHM | Securities Administration | — | 06021 | |
| 16 July 2026, 09:04 | CHM CDH17 Phase 1 clinical trial update - New DL 3 data | Company Update | MS | 11001 | |
| 14 July 2026, 17:11 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 14 July 2026, 16:28 | Notification of cessation of securities - CHM | Securities Administration | — | 06027 | |
| 7 July 2026, 14:41 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 6 July 2026, 09:01 | Board Update | Company Administration | — | 12001 | |
| 2 July 2026, 16:24 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 1 July 2026, 09:01 | Appointment of Financial Adviser for Strategic Review | Company Update | MS | 11001 | |
| 11 June 2026, 17:08 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 1 June 2026, 16:52 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 1 June 2026, 08:27 | CHM announces positive Phase 1/2 data at ASCO | Company Update | MS | 11001 | |
| 20 May 2026, 17:09 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 12 May 2026, 17:32 | Notice under section 708A | Securities Administration | — | 06018 | |
| 12 May 2026, 17:25 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 12 May 2026, 17:20 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 8 May 2026, 17:33 | Proposed issue of securities - CHM | Securities Administration | — | 06013 | |
| 5 May 2026, 17:02 | Notification of cessation of securities - CHM | Securities Administration | — | 06027 | |
| 5 May 2026, 14:07 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 4 May 2026, 16:45 | Notification regarding unquoted securities - CHM | Securities Administration | — | 06021 | |
| 4 May 2026, 16:25 | Notice under section 708A | Securities Administration | — | 06018 | |
| 4 May 2026, 16:20 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 1 May 2026, 17:30 | Application for quotation of securities - CHM | Securities Administration | — | 06020 | |
| 30 Apr 2026, 11:40 | Notification regarding unquoted securities - CHM | Securities Administration | — | 06021 | |
| 30 Apr 2026, 11:25 | Notification regarding unquoted securities - CHM | Securities Administration | — | 06021 | |
| 29 Apr 2026, 15:41 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 09:30 | Capital Consolidation Complete | Securities Administration | — | 06005, 06007 | |
| 29 Apr 2026, 09:23 | Update - Consolidation/Split - CHM | Securities Administration | — | 06005, 06007 | |
| 27 Apr 2026, 09:15 | CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi | Company Update | MS | 11001 | |
| 17 Apr 2026, 12:34 | Update - Consolidation/Split - CHM | Securities Administration | — | 06005, 06007 | |
| 17 Apr 2026, 12:22 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 9 Apr 2026, 16:28 | Notification of cessation of securities - CHM | Securities Administration | — | 06027 |
1–50 of 105
1 / 3